DSM-Firmenich

DSFIR

CH1216478797

Consumer Goods Conglomerates

End-of-day quote Euronext Amsterdam Other stock markets 2026-02-13			5-day change	1st Jan Change
62.82 ^CHF	-0.66%		-10.92%	-8.64%

02-13	Kepler Cheuvreux Downgrades DSM-Firmenich to Hold, Cuts PT	MT
02-12	DSM-Firmenich: Profitability disappoints in FY25

DSM Firmenich : dsm firmenich completes the sale of yeast extract business to Lesaffre

Published on 10/02/2024 at 03:04 am EDT - Modified on 10/02/2024 at 03:05 am EDT

Publicnow

DSM-FIRMENICH

-0.66%

DSM-Firmenich AG

DSM-Firmenich AG

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

Registration date02 oct 2024 - 07:22

Statutory nameDSM-Firmenich AG

Titledsm-firmenich completes the sale of yeast extract business to Lesaffre

Previous result

Next result

Related downloads

202410020000000001_Press release_dsm-firmenich Completes sale of yeast extract business to Lesaffre_20241002_FINAL.docx(opens in a new window)

202410020000000001_Press release_dsm-firmenich Completes sale of yeast extract business to Lesaffre_20241002_FINAL.pdf(opens in a new window)

Date last update: 02 October 2024

Disclaimer

DSM-Firmenich AG published this content on October 02, 2024 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on October 02, 2024 at 07:04:01 UTC.

Latest news about DSM-Firmenich

02-13	Kepler Cheuvreux Downgrades DSM-Firmenich to Hold, Cuts PT	MT
02-12	DSM-Firmenich: Profitability disappoints in FY25
02-12	DSM-Firmenich AG Proposes Cash Dividend for the Financial Year 2025	CI
02-12	Dsm-firmenich posts profit miss days after animal health sale, shares fall	RE
02-12	DSM-Firmenich AG, 2025 Earnings Call, Feb 12, 2026
02-12	U.S. Futures Slightly Up, European Stocks Rise	DJ
02-12	DSM-Firmenich AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
02-12	DSM-Firmenich to Kick off EUR500 Million Stock Repurchase Plan	MT
02-12	Dsm-firmenich reports Q4 core profit miss	RE
02-12	DSM-Firmenich Swings to FY25 Net Loss; Sales Decline	MT
02-12	DSM-Firmenich Q4 adj. EBITDA incl. discontinued operations at EUR 479 mln	RE
02-10	Brazil feedlot census shows 9.25 mln head in confinement	RE
02-09	All or Nothing Week
02-09	DSM Firmenich Share Slump Weighs on Symrise and Givaudan	DP
02-09	CVC Capital Partners plc agreed to acquire 80% stake in Animal Nutrition & Health business of DSM-Firmenich AG from DSM-Firmenich AG for ?1.7 billion.	CI

Chart DSM-Firmenich

Duration

Period

DSFIR: Dynamic Chart

Company Profile

DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.

Employees

28,550

Sector

Consumer Goods Conglomerates

Calendar

05-05 - Q1 2026 Sales and Revenue Release - Trading Update

More about the company